The Workgroup for Electronic Data Interchange advisory group yesterday urged Health and Human Services Secretary Xavier Becerra to work closely with standards development organizations and other health care partners to identify and pilot test appropriate No Surprises Act standards, harmonize them with existing and forthcoming standards and workflows, and implement them in stages. The letter also asks for extended enforcement discretion for the convening provider requirement until a standard is identified and implemented. 
 
“With no established standards and automated workflows, providers and facilities will face challenges identifying who the convening provider/facility should be, who the appropriate co-providers/facilities should be, how to collect [Good Faith Estimates] from these coproviders/facilities, and how to transmit GFEs to the patient’s health plan,” the letter notes. “…All stakeholders will face hurdles meeting the legislation’s deadlines to get GFEs and [Advanced Explanation of Benefits] to the patient.”
 
Terrence Cunningham, AHA’s director of administrative simplification policy, co-chairs WEDI’s No Surprises Act workgroup.

Related News Articles

Headline
The AHA July 15 commented to Sens. Sheldon Whitehouse, D-R.I., and Bill Cassidy, R-La., responding to a request for information based on the Pay PCPs Act,…
Headline
The House Appropriations Committee July 10 voted 31-25 to approve legislation that would provide $185.8 billion in funding for the departments of Labor, Health…
Headline
The House Energy and Commerce Committee June 12 passed AHA-supported legislation during a markup of bills that passed the Health Subcommittee in May. The…
Headline
The AHA praised House and Senate leaders in letters June 12 for reintroducing the Improving Seniors’ Timely Access to Care Act, bipartisan legislation that…
Headline
The AHA June 7 submitted comments on a discussion draft of the Drug Shortage Prevention and Mitigation Act, bipartisan legislation proposing to provide…
Headline
The House Energy and Commerce Oversight and Investigations subcommittee June 4 hosted a hearing to discuss oversight of the 340B Drug Pricing Program. AHA sent…